Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration: Two-Year Safety Results of the Two Prospective, Multicenter, Controlled Clinical Trials

This publication has 21 references indexed in Scilit:

• Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
  Archives of Ophthalmology (1950), 2004
• Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate
  American Journal of Ophthalmology, 2002
• Prevention of Experimental Choroidal Neovascularization With Intravitreal Anti–Vascular Endothelial Growth Factor Antibody Fragment
  Archives of Ophthalmology (1950), 2002
• Intrachoroidal Neovascularization in Transgenic Mice Overexpressing Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium
  The American Journal of Pathology, 2001
• Vascular Endothelial Growth Factor Is Sufficient to Produce Iris Neovascularization and Neovascular Glaucoma in a Nonhuman Primate
  Archives of Ophthalmology (1950), 1996
• Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman Primate
  Archives of Ophthalmology (1950), 1996
• Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
  Proceedings of the National Academy of Sciences, 1995
• Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
  New England Journal of Medicine, 1994
• Detection of Vascular Endothelial Growth Factor Messenger RNA and Vascular Endothelial Growth Factor-like Activity in Proliferative Diabetic Retinopathy
  Archives of Ophthalmology (1950), 1994
• Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy
  American Journal of Ophthalmology, 1994